
|Videos|August 3, 2020
ASRS 2020: Dexamethasone intracameral drug-delivery suspension in vitreoretinal surgery inflammation
Author(s)Alex Delaney-Gesing
Daniel F. Kiernan, MD, FACS, speaks on the key findings and take-aways of his presentation "Dexamethasone intracameral drug-delivery suspension for inflammation associated with vitreoretinal surgery."
Advertisement
Daniel F. Kiernan, MD, FACS, speaks with Ophthalmology Times®' David Hutton on the key findings and take-aways from his presentation, "Dexamethasone intracameral drug-delivery suspension for inflammation associated with vitreoretinal surgery," during the virtual 2020 American Society of Retina Specialists (ASRS) annual meeting.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Modern Retina
1
Geographic atrophy: When lesion borders cannot be graded
2
Clinical Trials at the Summit 2026: First-time data, AI, and the next generation of retinal treatments
3
The Retina TL;DR with Dr. Weng: Clinical trials, career, and community with David A. Eichenbaum, MD, FASRS
4
FDA guidance to help accelerate cell and gene therapies
5




















